Grzegorz Kreiner, PhD


Grzegorz Kreiner, PhD
Position
Research assistant

Assistant professor at Institute of Pharmacology PAS, Dept. Brain Biochemistry. Principal Investigator on two research grants funded by National Science Center (NCN):

Opus7 2014/13/B/NZ7/02293: Evaluation of the role of transcription factor CREB in the mechanism of antidepressant treatment: study on the novel genetic models based on the Cre/loxP system (2015-2018)

Opus13 2017/25/B/NZ7/02406: Evaluation of the influence of progressive noradrenergic neurodegeneration on dopaminergic system functioning in context of presymptomatic phase of Parkinson's disease (2018-2021)



More publications
  • Evaluation of the influence of progressive noradrenergic neurodegeneration on dopaminergic system functioning in context of presymptomatic phase of Parkinson's disease. - 2018-01-03 - 2021-01-02
    OPUS13 2017/25/B/NZ7/02406
    Principal Investigator: Dr Grzegorz Kreiner
  • Evaluation of the role of transcription factor CREB in the mechanisms antidepressant treatment - 2015-01-27 - 2018-11-26
    OPUS7 2014/13/B/NZ7/02293
    Principal Investigator: Dr Grzegorz Kreiner
  • Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodegeneration, based on tissue specific inducible Cre/loxP system - 2012-08-22 - 2016-04-21
    OPUS2 2011/03/B/NZ7/05949
    Principal Investigator: Dr Grzegorz Kreiner
  • Investigation of noradrenergic and glucocorticoid system interactions in GRDBHCre mice and their evaluation as a potential model of depression - 2010-02-01 - 2014-12-31
    POIG 01.01.02-12-004/09 DeMeTer (Depression – Mechanisms – Therapy). 
    Task 1.1 Subtask 1.1.2. Main topic: Modelling of depression – strategy of learning about its aetiology. Principal Investigator of task 1.2: Dr Grzegorz Kreiner

national

international

  • Dr Andrii Domanskyi, Institute of Biotechnology, University of Helsinki, Finland
  • Dr Rosanna Parlato, Institute of Applied Physiology, University of Ulm, Germany